Two years ago, Bill Revels was injected with millions of extremely small glass beads 鈥� an innovative medical procedure that ended up saving his life.
Revels had been diagnosed with liver cancer after experiencing pains in his side and back. 鈥淲hen I went into the hospital, I found I had a lesion on the liver,鈥� he says.
Doctors told Revels surgery wasn鈥檛 an option, and his first chemotherapy treatments were unable to stop the tumour鈥檚 growth. That鈥檚 when Dr. Bob Abraham called to inform Revels there was another option.
鈥淲ith glass? That sounds kind of funny,鈥� Revels recalls telling the doctor over the phone after he explained the Y-90 radioembolization procedure. The procedure uses radiation-emitting glass beads to target a tumour directly while avoiding harm to other parts of the body.
鈥淗e was able to come in the morning have the procedure done. The procedure itself is painless and he didn鈥檛 even know that we had actually injected the therapy. He was able to go home that afternoon,鈥� says Dr. Abraham (pictured right), Revel鈥檚 treating physician and an interventional radiologist at the QEII.
The procedure is just one of the exciting opportunities possible with research in the biomaterials field 鈥� possibilities that researchers and doctors are hoping to expand upon with the creation of a new biomaterials lab at 新澳门六合彩 to be funded by this year鈥檚 Molly Appeal campaign.
The annual fundraising campaign, led by the (DMRF), first started in 1980 when Molly Moore gave five dollars to the foundation 鈥� it鈥檚 first donation. Forty years later, the DMRF is still working to innovate in health care. This year, the foundation is asking Maritimers to help make a difference in the next generation of biomaterials research by giving what they can.
Improving care and patient outcomes
With the new Biomaterials Innovation Centre, researchers will work on a range of new treatments and products for conditions like Revel鈥檚 liver tumor to new orthopaedic implants.
鈥淲hat鈥檚 so exciting is that this lab will be able to touch so many disease processes and improve care and outcome of the patients that we treat in so many ways,鈥� says Dr. Abraham. 鈥淏iomaterials can be developed to be used in every part of the body and can improve treatments for so many diseases including cancer as we have seen with Y-90 therapy.鈥�
Revels says the only side effect after his Y-90 procedure: some tiredness for a few weeks after the treatment. Two years after the procedure he is able to live a normal, happy life.
鈥淚t鈥檚 one of the most rewarding things about my life. I鈥檓 able to make these kinds of differences with these patients,鈥� says Dr. Abraham. 鈥淭o be able to see him go back to work, be able to support [his] family, support himself and feel well after a diagnosis of liver cancer is truly amazing and a biomaterial is what has allowed this to happen.鈥澛犅�
Dr. Abraham continues to work on the next step in the Y-90 radioembolization procedure.
鈥淲e actually are creating the next level of Y-90 therapy with new glass beads that are therapeutic but that you can actually visualize as we鈥檙e injecting,鈥� he says. Using a CT scan, doctors will be able to see the treatment as it works and verify its success as it happens. The new biomaterial used in the procedure will soon be entering a clinical trial.
Revels says he鈥檚 thankful to the doctors and researchers who work on these innovative procedures that turned his life around and is happy to share his success story to raise awareness about the impact the Molly Appeal can have.
鈥淲hat鈥檚 so great about this campaign and fundraising is that it鈥檚 going to bring a lot of very dedicated, passionate and talented people together in one location to create all these new products,鈥� says Dr. Abraham.
Through the Molly Appeal fundraising, and more innovative research emerging out of Dalhousie in the biomaterials field, there is hope for new life-changing procedures. If you鈥檙e interested in donating to the Dalhousie Medical Research Foundation, .